2 hours ago
5
Key Highlights
- Shares of Rocket Lab advanced approximately 1.1% to $75.67, after reaching an intraday peak of $80.19
- The aerospace firm successfully executed its 92nd Electron launch, marking the 13th mission in 2026
- A $397 million Space Force contract was secured for the company’s SB-AMTI satellite initiative
- Combined Space Force awards totaled roughly $663 million, contributing to a backlog of approximately $2.2 billion
- Second quarter 2026 financial results scheduled for August 10; Wall Street projects $231.79 million in revenue versus $144.50 million year-over-year
Shares of Rocket Lab experienced upward momentum Thursday, reaching an intraday high of $80.19 before closing near $75.67, representing an approximate 1.1% gain from Wednesday’s close of $74.82.
The stock’s positive performance followed an eventful period marked by operational achievements and significant contract announcements that captured market attention.
The aerospace company executed its 92nd Electron launch Thursday from its New Zealand facility in Mahia. This mission represented the eighth deployment for the IQPS Earth observation constellation and marked the company’s 13th Electron mission year-to-date in 2026.
In a major development, the U.S. Space Force granted Rocket Lab a $397 million agreement to build, launch, and manage Flatellite spacecraft supporting the Space-Based Airborne Moving Target Indicator initiative. The Flatellite system targets deployment in large-scale satellite networks.
Including an additional major launch services agreement, Rocket Lab’s cumulative Space Force contract awards over recent weeks totaled roughly $663 million. This brings the company’s overall backlog to approximately $2.2 billion.
Certain SB-AMTI launches will require Rocket Lab’s Neutron vehicle, which remains in development and has not yet completed its maiden flight.
Wall Street Perspective
Analyst sentiment toward the stock remains generally optimistic. The consensus stands at “Moderate Buy” with a mean price objective of $110.29 among analysts surveyed by MarketBeat. KeyCorp maintains the highest target at $135, while Piper Sandler holds a Neutral stance with an $83 price objective.
On July 27, KGI Securities elevated Rocket Lab to an Outperform rating with a $107 target. Bank of America increased its price objective from $105 to $115 in late June while reaffirming its Buy recommendation.
Upcoming Financial Release
Market focus now shifts to August 10, when Rocket Lab will unveil its Q2 2026 financial performance following market close. Consensus estimates call for a loss of 7 cents per share, an improvement from the 13 cents loss reported in the comparable quarter last year.
Revenue forecasts stand at $231.79 million, representing substantial growth from the $144.50 million recorded a year earlier.
During the first quarter of 2026, Rocket Lab delivered revenue of $200.35 million, a 63.4% year-over-year increase that surpassed analyst projections of $189.65 million.
The company maintains a market capitalization of $43.79 billion and currently shows a negative P/E ratio of -236.47. With a beta of 2.60, the stock exhibits elevated volatility characteristic of the sector.
Company insiders have divested more than 3.8 million shares worth approximately $362.8 million during the past three months. On July 8, CEO Peter Beck sold 990,960 shares at an average execution price of $82.86, decreasing his holdings by 36.5%.
The equity’s 50-day moving average rests at $91.53, while its 200-day moving average stands at $85.99, both positioned above current trading levels.
Institutional investors control 71.78% of outstanding shares, with Bank of New York Mellon Corp establishing a fresh position valued at roughly $201.5 million during Q2.
The post Rocket Lab (RKLB) Stock Gains Momentum Following Major Space Force Contract Awards appeared first on Blockonomi.
English (US) ·